1. Home
  2. FORM vs KRYS Comparison

FORM vs KRYS Comparison

Compare FORM & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$147.35

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$304.19

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
KRYS
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.8B
IPO Year
2002
2017

Fundamental Metrics

Financial Performance
Metric
FORM
KRYS
Price
$147.35
$304.19
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$98.25
$297.60
AVG Volume (30 Days)
2.0M
245.1K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
0.26
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
$19.43
$38.74
Revenue Next Year
$7.31
$32.53
P/E Ratio
$556.25
$161.85
Revenue Growth
N/A
33.94
52 Week Low
$27.00
$123.03
52 Week High
$159.09
$303.00

Technical Indicators

Market Signals
Indicator
FORM
KRYS
Relative Strength Index (RSI) 63.72 72.17
Support Level $129.25 $238.45
Resistance Level $159.09 N/A
Average True Range (ATR) 9.97 13.30
MACD -0.77 3.27
Stochastic Oscillator 62.05 97.73

Price Performance

Historical Comparison
FORM
KRYS

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: